POMPANO BEACH, FLORIDA., March 07, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (BSEM), announced today that it has entered into an Agreement to acquire the majority of the assets of Auxocell ...
BioStem Technologies announced Tuesday morning that it is acquiring the majority of Auxocell Laboratories’ assets. BioStem is a company which utilizes perinatal tissue in the “development, ...